Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02056821 · ClinicalTrials.gov registry record
Hemodynamic Effects on Cerebral Autoregulation in Acute Stroke
A clinical trial of Ischemic Stroke, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 88
- Enrollment target
- 1
- Study location
NCT02056821: Completed study of Ischemic Stroke, sponsored by Henry Ford Health System.
NCT02056821 is a study of Ischemic Stroke that has completed, run by Henry Ford Health System. The registered enrollment target is 88 participants, below the 1,462-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02056821, a study of Ischemic Stroke, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates if there are hemodynamic alterations in acute stroke that predispose patients to impaired perfusion and regulation of cerebral blood flow. To test this, we will target recruitment of acute ischemic stroke patients who present to the ED within 12 hours of symptoms onset. Enrolled subjects will receive continuous noninvasive hemodynamic monitoring contemporaneous with measurements of cerebral blood flow velocities and cerebral oximetry.
Primary Outcome
Cerebral flow velocities determined by bilateral MCA measurements by TCD
Conditions Studied
Study Locations (1)
Michigan
- Henry Ford Hospital - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-05 |
What the finished NCT02056821 record still lists
NCT02056821 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,462-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 0 interventions.
NCT02056821 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT02056821 about?
NCT02056821 is a clinical study titled "Hemodynamic Effects on Cerebral Autoregulation in Acute Stroke". This study investigates if there are hemodynamic alterations in acute stroke that predispose patients to impaired perfusion and regulation of cerebral blood flow. To test this, we will target recruitment of acute ischemic stroke patients who present to the ED within 12 hours of symptoms onset. Enrol...
What is the current status of trial NCT02056821?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2014-02. Estimated completion is 2016-05.
What conditions does trial NCT02056821 study?
This clinical trial studies the following conditions: Ischemic Stroke.
Who is sponsoring clinical trial NCT02056821?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02056821 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02056821's enrollment target sits among peer trials
88 33rd of 66 higher than 34 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Transitions of Care for Stroke Patients
RECRUITING
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia